Anne Marie Ripley consults in the medical device industry, focusing primarily on clinical and regulatory affairs. She’s spent most of her 25-year career working as a senior executive in medical device start-up companies, including Sight Sciences, Second Sight, and Eclipse Surgical Technologies, helping them take products from design conception through market approval. She has focused on ophthalmology for the past 15 years, but has also worked in a variety of other therapeutic areas including stroke and spinal cord injury, interventional cardiology, and cardiac surgery. Ms. Ripley has worked on devices ranging from class I through class III, including extensive experience in active implantable devices, preparing a variety of regulatory submissions including pre-submissions, IDEs, 510(k)s, PMAs, CE Mark, HDEs, and HUDs. She’s designed and executed numerous feasibility, pivotal, and post-market clinical studies conducted in the US, Europe and other OUS markets.